Hefei Lifeon Pharmaceutical Co Ltd (003020) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.343x

Based on the latest financial reports, Hefei Lifeon Pharmaceutical Co Ltd (003020) has a cash flow conversion efficiency ratio of 0.343x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥667.63 Million ≈ $97.69 Million USD) by net assets (CN¥1.95 Billion ≈ $284.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Hefei Lifeon Pharmaceutical Co Ltd (003020) net asset quality to measure how much of total assets are equity-financed.

Hefei Lifeon Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Hefei Lifeon Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Hefei Lifeon Pharmaceutical Co Ltd cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Hefei Lifeon Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hefei Lifeon Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Yuanta Sec Kor KO:003470	-0.033x
Idaho Strategic Resources Inc NYSE MKT:IDR	0.031x
ATRenew Inc DRC NYSE:RERE	0.006x
Mercuries & Associates Holding Ltd TW:2905	-0.043x
Nanjing Canatal Data Centre Environmental Tech Co Ltd Class A SHG:603912	0.024x
Kambi Group PLC Series B LSE:0EAW	0.089x
Hangzhou Huaguang Advanced Welding Materials Co Ltd SHG:688379	-0.013x
Regulus Therapeutics Inc NASDAQ:RGLS	-0.154x

Annual Cash Flow Conversion Efficiency for Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Hefei Lifeon Pharmaceutical Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.95 Billion ≈ $285.59 Million	CN¥212.89 Million ≈ $31.15 Million	0.109x	+5.62%
2024-12-31	CN¥1.91 Billion ≈ $279.87 Million	CN¥197.53 Million ≈ $28.91 Million	0.103x	-5.00%
2023-12-31	CN¥1.87 Billion ≈ $274.15 Million	CN¥203.67 Million ≈ $29.80 Million	0.109x	-19.80%
2022-12-31	CN¥1.48 Billion ≈ $216.60 Million	CN¥200.64 Million ≈ $29.36 Million	0.136x	+11.37%
2021-12-31	CN¥1.30 Billion ≈ $190.80 Million	CN¥158.70 Million ≈ $23.22 Million	0.122x	-17.16%
2020-12-31	CN¥1.17 Billion ≈ $171.79 Million	CN¥172.49 Million ≈ $25.24 Million	0.147x	-41.94%
2019-12-31	CN¥590.00 Million ≈ $86.34 Million	CN¥149.30 Million ≈ $21.85 Million	0.253x	+98.55%
2018-12-31	CN¥505.70 Million ≈ $74.00 Million	CN¥64.45 Million ≈ $9.43 Million	0.127x	+307.11%
2017-12-31	CN¥361.71 Million ≈ $52.93 Million	CN¥11.32 Million ≈ $1.66 Million	0.031x	-84.18%
2016-12-31	CN¥298.09 Million ≈ $43.62 Million	CN¥58.99 Million ≈ $8.63 Million	0.198x	-53.66%
2014-12-31	CN¥215.53 Million ≈ $31.54 Million	CN¥92.05 Million ≈ $13.47 Million	0.427x	+112.57%
2013-12-31	CN¥176.88 Million ≈ $25.88 Million	CN¥35.54 Million ≈ $5.20 Million	0.201x	+458.44%
2012-12-31	CN¥141.96 Million ≈ $20.77 Million	CN¥-7.96 Million ≈ $-1.16 Million	-0.056x	--

About Hefei Lifeon Pharmaceutical Co Ltd

SHE:003020 China Biotechnology

Market Cap

$565.39 Million

CN¥3.86 Billion CNY

Market Cap Rank

#11460 Global

#3192 in China

Share Price

CN¥16.93

Change (1 day)

+0.36%

52-Week Range

CN¥14.66 - CN¥38.76

All Time High

CN¥38.76